Teva Launches Generic Actoplus Met

Teva Pharmaceutical announced the launch of Pioglitazone/Metformin Tablets, the generic version of ACTOplus met, marketed by Takeda Pharmaceuticals USA.

ACTOplus met, a thiazolidinedione and biguanide combination, is indicated as an adjunct to diet and exercise to improve glycemic control in type 2 diabetes in adult patients already on pioglitazone and metformin, or when response to pioglitazone or metformin alone is inadequate.

Pioglitazone/Metformin Tablets from Teva are available in two dosage strengths: 15mg/500mg and 15mg/850mg.

For more information call (888) TEVA-USA or visit